SCLN Financial Facts
General and administrative: 7.9MIncome from operations: 10.45M
See Full Income Statement
Accrued and other current liabilities: 19.88M
Accumulated deficit: -94.18M
See Full Balance Sheet
SciClone Pharmaceuticals, Inc. (SCLN) Earnings
|
Expand Research on SCLN
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +203.3% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +2.1% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/9/12 | Q312 | $0.20 | $0.21 | -$0.01 | $40.7M | $44.8M | Details | ||||
11/9/16 | Q316 | $0.24 | N/A | N/A | $40.5M | $42.9M | N/A | Details | |||
8/8/12 | Q212 | $0.19 | $0.17 | +$0.02 | $40.3M | $41.98M | Details | ||||
3/10/16 | Q415 | $0.30 | N/A | N/A | $42.9M | $41.1M | N/A | Details | |||
3/13/12 | Q411 | $0.20 | $0.12 | +$0.08 | $41.4M | $40.39M | Details | ||||
5/10/17 | Q117 | $0.31 | $0.14 | +$0.17 | $42.9M | $39.94M | = | Details | |||
11/12/13 | Q313 | $0.18 | $0.15 | +$0.03 | $35.2M | $39.7M | = | Details | |||
3/12/14 | Q413 | $0.08 | $0.15 | -$0.07 | $32.7M | $38.3M | Details |